<DOC>
	<DOCNO>NCT01826045</DOCNO>
	<brief_summary>The purpose study determine efficacy safety PGA ( Poly-gamma Glutamic Acid ) fertile woman Cervical Intraepithelial Neoplasia ( CIN1 ) .</brief_summary>
	<brief_title>Efficacy Safety Study PGA ( Poly-gamma Glutamic Acid ) Cervical Intraepithelial Neoplasia</brief_title>
	<detailed_description>This study compare regression rate Cervical Intraepithelial Neoplasia ( CIN1 ) treatment group control group . The treatment group administer PGA ( Poly-gamma Glutamic Acid ) 4 week follow 8 week observation . The control group observe 12 week without comparator .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<criteria>Fertile woman age 20 49 Patients cervical intraepithelial neoplasia 1 ( CIN1 ) HPV ( Human Papilloma Virus ) positive ( + ) White Blood Cell Count ( WBC ) 4thous/ul , Hemoglobin 9.0g/dL Platelet 150thous/uL ANC ( Absolute Neutrophil Count ) 1,500 10^6/L AST ( Aspartate Aminotransferase ) less 4 time higher normal ALT ( Alanine Aminotransferase ) less 4 time higher normal Normal EKG ( Electrocardiography ) active disease detect trough chest Xray Be inform nature study give write informed consent Malignant tumor organ cervical intraepithelial neoplasia Active liver disease , immune disorder severe renal failure Leukemia , collagenosis , sclerosis , autoimmune disease , clinically significant allergic disease ( mild allergic symptom require medicine exclude ) Diagnosed diabetes Taking following affect immunological reaction within 7 day ( Glucocorticoid , vitamins , health food oriental medicine etc ) Pregnancy breastfeed Registered clinical trial Patients investigator considers inappropriate participate study</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Treatment Cervical Intraepithelial Neoplasia ( CIN1 )</keyword>
</DOC>